Hello Share Munchers. A very useful company is commended today, one which should benefit from the growing army of GP patients. I don't know about you, but it's almost impossible for this family to see a real doctor these days. This is not always due to a shortage of them, but a fast-growing number of older patients suffer more than one chronic illness...
Hello, Share Smackers. Operating profit for 2017 dropped by more than half at EMIS Group (EMIS). According to the figures just out, £11.2 million was used up covering service and reporting issues. That seems fairly remiss in a modern company which should always be equipped to pleasing its big customers.
A Trading Statement from EMIS Group (EMIS) commences “trading for the year has been in line with the board's expectations”. Ok… “(excluding the impact of the service level reporting issues separately announced this morning)”. Uh oh…
A trading update announcement from EMIS Group (EMIS) includes that “performance for the year was in line with the board's expectations”, so why are the shares currently around 8% lower, at 870p?...
From the FCA's spreadsheet of short positions required to be disclosed to it, the following details the shorted AIM shares at the end of January 2016 (by net short position %) - and if the positions have increased (red), reduced (green) or remained unchanged (black) since last month...
Hello Share Swipers. I hope you’ve not had call to visit your doctor lately. But if you have, you’ve probably noticed a difficulty getting your appointment and a bursting surgery once you finally you got there.
Shares in EMIS Group (EMIS), a leading UK supplier of clinical software and related services to GP practices and other healthcare practitioners and a major software supplier to high street pharmacies, commenced 2013 at more than 900p but fell more than 16.5% (to 750p) on 24th January as the company reported “lower than planned revenues from the Australian defence contract, training and integrated care services. Group adjusted operating profit is expected to be marginally below analysts’ expectations, largely as a result of the accelerated staff and recruitment costs associated with the EMIS Web roll out and the slight revenue shortfalls highlighted above”. The shares have further declined since to trade at a current 650p, capitalising this AIM-listed company at £380.5 million. The following analyses whether this current, lower level represents value…
Search ShareProphets |
Recent Comments |